SNSE – sensei biotherapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

SNSE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/7

08:00 am

snse

Egle Therapeutics Appoints John Celebi as Chief Executive Officer

Medium Report

Egle Therapeutics Appoints John Celebi as Chief Executive Officer

Report

12/27

01:05 am

snse

Sensei Biotherapeutics (NASDAQ:SNSE) was upgraded by analysts at Wall St

Low Report

Sensei Biotherapeutics (NASDAQ:SNSE) was upgraded by analysts at Wall St

Report

11/20

01:38 pm

snse

Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

11/14

07:30 am

snse

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Medium Report

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.